Mira Pharmaceuticals Files 10-K/A Amendment
Ticker: MIRA · Form: 10-K/A · Filed: Apr 15, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 10-K/A |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
Mira Pharma filed an amendment to its 2024 annual report. Check for updates.
AI Summary
Mira Pharmaceuticals, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly known as Mira1a Therapeutics, Inc. until January 12, 2022, is incorporated in Florida and headquartered in Miami. This amendment likely provides updated or corrected information for the period.
Why It Matters
This filing indicates that Mira Pharmaceuticals is providing updated or corrected information for its 2024 annual report, which could contain material details for investors.
Risk Assessment
Risk Level: medium — Amendments to annual reports can signal that the original filing contained errors or omissions, potentially impacting the company's financial or operational status.
Key Numbers
- 001-41765 — SEC File Number (Identifies the company's filings with the SEC.)
- 85-3354547 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- Mira Pharmaceuticals, Inc. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 20250415 (date) — Filing date
- 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131 (address) — Principal executive offices
FAQ
What specific information is being amended in the 10-K/A filing?
The filing document 'form10-ka.htm' is marked as true, indicating it is the primary amended document, but the specific details of the amendments are not provided in this header information.
When was Mira Pharmaceuticals, Inc. previously known as Mira1a Therapeutics, Inc.?
The company changed its name from Mira1a Therapeutics, Inc. on January 12, 2022.
What is the principal executive office address for Mira Pharmaceuticals, Inc.?
The principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
What is the SIC code for Mira Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
On what date was this amendment filed with the SEC?
This amendment was filed on April 15, 2025.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 15, 2025 regarding MIRA PHARMACEUTICALS, INC. (MIRA).